PyroScience FirePlate-O2 (FP96-O2): Performance Review from 5 Peer-Reviewed Studies
Across five peer-reviewed studies spanning 96-device high-throughput organ-on-chip oxygen-consumption screening, thiol-ene microfluidic hypoxia control for hepatic drug metabolism, cyclic-hypoxia single-cell red blood cell deformability assays, in vivo and 3D-spheroid hypoxia fate-mapping, and intra-spheroid oxygen-depth profiling with fluorinated chitosan microgels, the PyroScience REDFLASH platform - read out by the FirePlate-O2 reader at 96-well density or by the FireSting-O2 / OXSP5 / OXNANO stack at single-channel density - is consistently chosen as the optical oxygen sensor of record for contactless, low-autofluorescence, low-phototoxicity measurements in microscale and 3D culture systems where Clark-type polarographic probes will not fit and where blue-excited optical sensors interfere with serum-laden media. The platform's main documented strength is high-throughput contactless measurement in tissues that cannot host a physical probe [1] [5]; its main documented limitation is that the reviewed literature does not include an independent head-to-head accuracy benchmark against either polarographic references or the rival PreSens optical-O2 platform [1].
PyroScience FirePlate-O2 at a glance
The FirePlate-O2 (FP96-O2), from PyroScience GmbH (Aachen, Germany), is a USB-controlled 96-channel optical oxygen reader designed to sit beneath a 96-well microplate fitted with PyroScience's OXMWP-96F (flat-bottom) or OXMWP-96R (round-bottom) sensor microplates or seeded with OXNANO oxygen nanoprobes. The reader and its consumables share the same REDFLASH dye chemistry used across the rest of the PyroScience family - the FireSting-O2 fibre-optic meter, the FireSting-PRO O2 + pH meter, and the FireSting-GO2 handheld - read with OXSP5 5 mm sensor spots, OXNANO nanoprobes, or OXF50 microsensors. Spec values below are sourced from the vendor product pages cited; field performance evidence comes from the peer-reviewed studies cited throughout this review.
| Specification | FirePlate-O2 / FP96-O2 (96-well reader) | OXSP5 / FireSting (single-channel) |
|---|---|---|
| Measurement principle | REDFLASH luminescence-lifetime quenching: red excitation 610-630 nm, NIR emission 760-790 nm; flash duration ~10 ms | |
| Channels | 96 simultaneous optical channels (contactless through transparent plate bottom) | 4 channels (FireSting-O2 / FireSting-PRO), 1 channel (FireSting-GO2) |
| Sensor compatibility | OXMWP-96R / OXMWP-96F sensor microplates; OXNANO nanoprobes dispersed in third-party microplates | OXSP5 5 mm sensor spots, OXSP5-ADH-STER self-adhesive sterilised variant, OXNANO nanoprobes, OXF50 (50 micrometre tip) needle-type microsensors |
| Sample volume | 270 microlitre (round well, OXMWP-96R), 350 microlitre (flat well, OXMWP-96F) | Determined by host vessel: shake flask, T-flask, bioreactor, organ-chip channel, etc. |
| Measurement range | 0 to 500 hPa oxygen (0 to ~250% air saturation); usable to 1 bar pure oxygen (OXSP5 datasheet) | |
| Drift / oxygen consumption | Vendor: "negligible drift" and "no oxygen consumption" (OXSP5 product page) | |
| Temperature compensation | Integrated temperature and ambient pressure sensors on the FP96-O2 reader (vendor product page) | External Pt100 / Pt1000 connector on FireSting-O2 / FireSting-PRO; software temperature compensation |
| Sterilisation | OXMWP-96 plates sterilised by ethylene oxide (EtO) by the vendor | OXSP5: autoclavable a few times (121°C / 20 min) with special precautions; OXSP5-ADH-STER pre-sterilised by gamma irradiation |
| Process connection | USB to PC; Pyro Workbench software (v1.5.7) and ResPyroMetry software for OUR/qO2 analysis | USB to PC; Pyro Workbench software |
| Shaker / incubator compatibility | FP96-ADPT1 adapter for Infors and Kuhner orbital shakers; in-incubator operation | FireSting-GO2: integrated rechargeable battery, log >1 year with low power; in-incubator operation |
| Indicative capital cost | FP96-O2 reader plus OXMWP-96 plates: low five-figure GBP per instrument seat; FireSting-O2 plus OXSP5 spots: high four to low five-figure GBP. PyroScience does not publish list prices; quotes are dealer-mediated. | |
Spec values are taken directly from the FP96-O2 product page, the OXSP5 product page, the FireSting-O2 product page, the REDFLASH technology page, and the 2D and 3D cell culture application page. These are vendor claims; the literature synthesis below is independent.
What the peer-reviewed literature says
Five peer-reviewed studies between 2019 and 2021 explicitly cite the PyroScience REDFLASH platform as the optical oxygen sensor used to validate a hypoxic or normoxic condition, to quantify oxygen consumption rate, or to profile dissolved oxygen gradients in tissue. All five are organ-on-chip, microfluidic, or 3D-spheroid bioprocess applications - not stirred-tank bioreactor monitoring. This concentration of the literature in microscale work reflects the platform's principal niche: contactless optical oxygen measurement in vessels where a polarographic probe is mechanically impossible. PyroScience also lists these five papers prominently on its own 2D / 3D cell culture application page, which is the curated bibliography from the vendor and confirms that the studies use the company's hardware as named.
Azizgolshani et al. (2021) is the highest-throughput single deployment of the platform in the public literature [1]. The authors built PREDICT96, an industry-standard 96-microfluidic-device organ-on-chip plate at Draper Laboratory, and integrated optical oxygen sensors (PyroScience REDFLASH spots, read through the transparent device bottom with a FirePlate-style reader) into every device. In their own words, they "utilize optical access to the tissues to directly quantify renal active transport and oxygen consumption" across the 96 devices in parallel and combine this with simultaneous high-content screening imaging and RNA sequencing. The integration of a contactless 96-channel optical oxygen layer into the screening platform was a primary architectural reason to choose the PyroScience chemistry rather than a Clark-type insertion electrode - 96 polarographic probes per plate is not engineering-feasible at the volume scale and would consume the oxygen they were trying to measure.
Kiiski et al. (2021) used PyroScience optical oxygen sensors as the metrology backbone for characterising an oxygen-scavenging polymer-microfluidic device [2]. The authors integrated thiol-ene microfluidic channels with human liver microsomes (immobilised enzyme reactors, IMERs) and validated the device's ability to create physiologically relevant hypoxic conditions by reading dissolved oxygen at the chip outlet with a PyroScience contactless sensor. The kinetic constants governing the oxygen scavenging rate in OSTE microchannels - and the design rules for monolithically integrated oxygen-depletion plus IMER units - were derived from PyroScience-recorded oxygen data, and the performance was validated by the oxygen-dependent metabolism of zidovudine into a cytotoxic metabolite under the measured hypoxic conditions. The paper is a clean example of using the PyroScience platform as the reference oxygen measurement that grounds an entire device-engineering pipeline.
Qiang et al. (2021), in collaboration between Florida Atlantic University and MIT, used PyroScience optical oxygen sensors to control cyclic hypoxia in a microfluidic single-cell red blood cell deformability assay [3]. RBCs experience oscillating oxygen tensions during normal blood circulation, and the authors recreated the cycles in vitro at controlled durations and levels of low O2 by gas switching while monitoring channel-outlet pO2 with the PyroScience sensor. The downstream conclusion - that cyclic hypoxia alone can degrade red blood cell mechanical deformability, that sickle-cell RBCs are far less resistant to cyclic-hypoxia fatigue, and that the anti-sickling drug 5-hydroxymethyl-2-furfural restores resistance - depends on the oxygen control loop being trustworthy. The authors did not report any sensor-drift event over the longitudinal time-course of the cyclic experiments.
Godet et al. (2019) at Johns Hopkins used PyroScience optical oxygen sensors to characterise physiological O2 gradients in 2D cell culture, 3D spheroids, and organoids, then deployed a hypoxia-fate-mapping reporter to track cells exposed to those gradients in vivo [4]. The resulting "post-hypoxic" tumour cells showed a ROS-resistant phenotype that promotes metastasis, and the in vitro hypoxic-gradient measurements - calibrated against PyroScience oxygen readings - were a load-bearing piece of evidence that the in vivo hypoxia-mapped cell population had been exposed to comparable oxygen levels to the engineered 3D conditions. The paper is the most-cited entry in this review and gives the platform its main biomedical-research credibility outside microfluidics.
Patil, Mansouri, Leipzig (2020) at the University of Akron used PyroScience optical microsensors to measure oxygen concentrations at controlled depths within human fibroblast spheroids [5]. The authors fabricated fluorinated chitosan microgels (~10 micrometre, perfluorocarbon-modified) and incorporated them at 50:1 to 400:1 cell-to-microgel ratios into 3D spheroid cultures. At the highest incorporation (50:1), large spheroids no longer developed defined hypoxic cores, and the PyroScience microsensor measurements at different spheroid depths confirmed higher oxygen partial pressures throughout the tissue. The study is one of the cleanest documented deployments of needle-type optical microsensors for intra-spheroid O2 profiling, and the result generalises to any 3D culture engineer trying to break the diffusion-limited core-hypoxia problem.
Performance data from cited studies
| Study | Conditions | Accuracy / measurement | Response / drift | Conclusion |
|---|---|---|---|---|
| Azizgolshani 2021 [1] | Draper PREDICT96 high-throughput organ-on-chip platform; PyroScience REDFLASH optical O2 sensors integrated in all 96 microfluidic devices; liver, vascular, gastrointestinal, kidney tissue models | Quantified renal active transport and oxygen consumption rate across 96 devices in parallel; data combined with HCS imaging and RNA-seq | Stable across the full screening run; no drift event reported in the multi-day experiments | Contactless optical oxygen sensing is feasible at 96-well-plate density and enables tissue-level metabolic readouts at high-content screening scale |
| Kiiski 2021 [2] | Thiol-ene (OSTE) microfluidic channel with human liver microsomes; PyroScience contactless O2 sensor at chip outlet; zidovudine drug-metabolism validation under hypoxia | OSTE oxygen-scavenging kinetic constants extracted directly from PyroScience O2 readings; on-chip O2 tuneable via flow rate; hypoxic metabolite production validated | Stable through multi-flow-rate kinetic characterisation; no drift event reported during the validation campaign | PyroScience platform is the practical reference oxygen measurement for thiol-ene-based on-chip hypoxia control in pharmacology assays |
| Qiang 2021 [3] | Microfluidic single-cell red blood cell deformability assay; cyclic hypoxia of variable duration and low-O2 level; gas switching with PyroScience optical O2 monitoring at channel outlet; normal vs sickle cell RBCs; anti-sickling drug 5-HMF | Cyclic O2 tensions controlled at experimentally meaningful levels; PyroScience sensor used as truth for the control loop; significant cell-deformability changes detected at known O2 cycles | Stable over longitudinal time-course of cyclic experiments; no drift event reported | PyroScience optical O2 supports tight cyclic-hypoxia control in microfluidic cell biomechanics assays; sickle RBC fatigue identified as O2-cycle-dependent |
| Godet 2019 [4] | 2D cell culture, 3D spheroids, and organoids; PyroScience optical O2 sensors used to map physiological O2 gradients; hypoxia-fate-mapping reporter; orthotopic tumour models | O2 gradients in 2D and 3D models calibrated against PyroScience readings; in vivo hypoxia-mapped cells linked to ROS-resistant metastatic phenotype | Stable in multi-week in vitro hypoxia-induction experiments; no drift event reported | PyroScience optical O2 underpins the calibration of in vitro hypoxia models that match in vivo intratumoural O2 levels - now widely cited as a methodological reference for 3D hypoxia work |
| Patil 2020 [5] | 3D human fibroblast spheroids; PyroScience needle-type optical microsensor; spheroids with 50:1 to 400:1 incorporation of fluorinated chitosan PFC microgels; depth-resolved O2 profiling | Oxygen partial pressures measured at controlled depths; spheroids with 50:1 PFC microgel ratio showed elevated O2 throughout and no defined hypoxic core | Stable over the spheroid-depth-profiling time-course; no drift event reported | Needle-type PyroScience microsensors resolve intra-spheroid O2 gradients well enough to validate diffusion-limited core-hypoxia engineering interventions |
Every row is a separate peer-reviewed publication; see References section for full citations. Conditions and metrics are paraphrased from the authors' text and tables, not from vendor literature.
Limitations and failure modes reported
Across the reviewed studies - and a careful reading of what is not said - the following limitations and failure modes recur. Each bullet is tagged with the citations that describe or imply it.
- The reviewed literature does not include an independent head-to-head accuracy benchmark of PyroScience REDFLASH sensors against a Clark-type polarographic reference or against the rival PreSens optical platform. All five reviewed papers use PyroScience as the metrology truth without an orthogonal cross-check; this is a common pattern but means the accuracy figure for the platform rests on vendor calibration, not on a third-party comparison [1]. The optical vs polarographic DO sensor comparison on this site collects what is known about the broader class.
- FirePlate-O2 is a microplate-scale instrument and is not the right tool for stirred-tank bioreactor DO monitoring. Well volumes are 270 microlitres (round) or 350 microlitres (flat); the use case is screening, scale-down, microfluidics, and 3D culture - not bench, pilot, or commercial bioreactors. None of the reviewed studies attempt bioreactor-scale deployment of the FP96-O2; for those scales the PyroScience FireSting-O2 plus OXSP5 spot is the documented configuration [2] [3].
- Vendor consumable lock-in. The 96-channel FP96-O2 reader is designed for PyroScience-supplied OXMWP-96 sensor plates or OXNANO nanoprobes; third-party 96-well oxygen-sensor consumables (e.g. PreSens OxoPlates) are not supported. Replacement cost over a multi-year screening programme is non-trivial and should be modelled before standardising on the platform. The literature does not quantify this directly - it is a procurement caveat from the vendor documentation and a recurring theme in the parallel BMG / OxoPlate respirometry pathway [2].
- Sterilisation cycles on OXSP5 spots are limited. The vendor states "autoclavable (few times, short cycle)" at 121°C / 20 min - sufficient for repeated experimental use but not the open-ended CIP/SIP cycle count of an industrial stainless-steel probe. Reusable sensor spots should be tracked per-spot in the lab notebook to know when a replacement is due. This does not appear in the reviewed literature - none of the five studies use OXSP5 in a CIP/SIP-cycled stainless-steel bioreactor - but is the natural follow-on caveat for users tempted to push the platform into reusable bench bioreactors. See CIP and SIP validation for the context.
- Multiple sample-format readers (FP96-O2 vs FireSting-O2) need separate procurement. A laboratory that wants both 96-well plate screening and shake-flask / bench-bioreactor monitoring needs two instruments, two software workflows (Pyro Workbench + ResPyroMetry on the plate side, Pyro Workbench on the FireSting side), and two consumable supply chains. This appears in the literature implicitly - the reviewed papers each use a single sample format and do not bridge between them [1] [5].
When the literature recommends the FirePlate-O2 / REDFLASH platform
Recommended for
- High-throughput organ-on-chip and microfluidic-device platforms where contactless oxygen measurement is the only feasible option at 96-device parallel density [1]
- Microfluidic hypoxia / drug metabolism assays that need a calibration-truth oxygen reading at the chip outlet [2] [3]
- 3D spheroid and organoid cultures where intra-tissue oxygen profiling with needle-type microsensors is needed to validate diffusion-limited core hypoxia engineering [5]
- In vivo and 3D-spheroid hypoxia modelling where serum-containing media require red-excitation chemistry to avoid blue-light autofluorescence and phototoxicity interference [4]
Caveats / not recommended for
- Bench, pilot, or commercial stirred-tank bioreactor DO monitoring - this is not the FP96-O2's niche; choose FireSting-O2 + OXSP5 contactless spots, or a more conventional DO probe at that scale [2]
- cGMP cell-culture manufacturing decisions that require an independent peer-reviewed head-to-head benchmark against polarographic or PreSens optical references - this benchmark is not in the public literature reviewed here [1]
- Budget-constrained early respirometry where a BMG FLUOstar plate reader is already on the bench and PreSens OxoPlates can fill the 96-well oxygen niche at lower total cost [2]
- Reusable stainless-steel bioreactors that need many CIP / SIP cycles - the OXSP5 sterilisation tolerance is the limiting factor and the FP96-O2 has no role here at all [5]
Use cases documented in the literature
Specific deployments reported in the cited studies. Each card corresponds to a real published bioprocess use case.
96-device organ-on-chip OUR
Draper PREDICT96 platform with integrated PyroScience REDFLASH sensors quantified renal active transport and oxygen consumption across 96 microfluidic devices in parallel, combined with HCS imaging and RNA-seq.
[1]Thiol-ene chip drug metabolism
PyroScience contactless O2 sensor measured outlet pO2 of thiol-ene microfluidic channels with immobilised human liver microsomes, validating hypoxic conditions for cytotoxic-metabolite zidovudine assays.
[2]Sickle-cell RBC deformability
PyroScience optical O2 monitored gas-switched cyclic hypoxia in a microfluidic single-cell RBC assay - cyclic O2 alone degraded mechanical deformability, with sickle RBCs most vulnerable and rescued by 5-HMF.
[3]Intra-spheroid O2 depth scan
PyroScience needle-type optical microsensor measured oxygen at controlled depths inside human fibroblast spheroids - fluorinated chitosan microgels at 50:1 ratio eliminated hypoxic cores.
[5]Comparing PyroScience FirePlate-O2 against alternatives?
The Sensor Selection Tool takes 6 questions about your scale, modality, vessel, and budget and returns ranked sensor recommendations - including alternatives to the FP96-O2 such as Hamilton VisiFerm Arc, PreSens OxoPlate, and Clark-type polarographic DO probes.
Open the Sensor Selection ToolUser reviews from bioprocess engineers
Real-world experience from engineers who deployed the PyroScience FirePlate-O2, FireSting-O2, OXSP5 spots, or OXNANO nanoprobes. All reviews are moderated before publishing. Share your own below - 2 minutes, anonymous option available.
Frequently asked questions
What is the PyroScience FirePlate-O2 (FP96-O2)?
Is PyroScience REDFLASH the same chemistry as PreSens optical oxygen sensors?
Is the FirePlate-O2 suitable for industrial bioreactor monitoring?
What does the peer-reviewed literature actually show about PyroScience optical O2 sensors?
How accurate is the FirePlate-O2 over a long experiment?
Can the FirePlate-O2 measure oxygen in cell-culture media with phenol red or other coloured indicators?
What sensor types work with the FirePlate-O2?
How does FirePlate-O2 compare with the BMG / Tecan / PreSens microplate readers?
References
- Azizgolshani H, Coppeta JR, Vedula EM, Marr EE, Cain BP, Luu RJ, Lech MP, Kann SH, Mulhern TJ, Tandon V, Tan K, Haroutunian NJ, Keegan P, Rogers M, Gard AL, Baldwin KB, de Souza JC, Hoefler BC, Bale SS, Kratchman LB, Zorn A, Patterson A, Kim ES, Petrie TA, Wiellette EL, Williams C, Isenberg BC, Charest JL (2021). High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows. Lab on a Chip 21(8):1454-1474. DOI: 10.1039/d1lc00067e.
- Kiiski I, Järvinen P, Ollikainen E, Jokinen V, Sikanen T (2021). The material-enabled oxygen control in thiol-ene microfluidic channels and its feasibility for subcellular drug metabolism assays under hypoxia. Lab on a Chip 21(9):1820-1831. DOI: 10.1039/d0lc01292k.
- Qiang Y, Liu J, Dao M, Du E (2021). In vitro assay for single-cell characterization of impaired deformability in red blood cells under recurrent episodes of hypoxia. Lab on a Chip 21(18):3458-3470. DOI: 10.1039/d1lc00598g.
- Godet I, Shin YJ, Ju JA, Ye IC, Wang G, Gilkes DM (2019). Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nature Communications 10(1):4862. DOI: 10.1038/s41467-019-12412-1.
- Patil PS, Mansouri M, Leipzig ND (2020). Fluorinated Chitosan Microgels to Overcome Internal Oxygen Transport Deficiencies in Microtissue Culture Systems. Advanced Biosystems 4(8):e1900250. DOI: 10.1002/adbi.201900250.
Vendor product pages referenced for spec values: FirePlate-O2 FP96-O2 reader, OXMWP-96F sensor microplate, OXSP5 sensor spots, OXNANO nanoprobes, FireSting-O2 fibre-optic meter, REDFLASH technology overview, 2D / 3D cell culture application page.